UFLEX Boosts Aseptic Packaging Capacity by 71% at Gujarat Facility

1 min read     Updated on 03 Oct 2025, 07:11 PM
scanx
Reviewed by
Ashish ThakurScanX News Team
Overview

UFLEX Limited has expanded its aseptic packaging production capacity at its Sanand, Gujarat facility from 7 billion to 12 billion packs annually, representing a 71% increase. The expansion, completed on October 3, 2025, was achieved through debottlenecking of the existing facility. This significant boost in capacity strengthens UFLEX's position in the aseptic packaging market, allowing the company to meet growing demands in the food and beverage industry.

21044466

*this image is generated using AI for illustrative purposes only.

UFLEX Limited, a leading flexible packaging company, has significantly expanded its aseptic packaging capabilities at its Sanand, Gujarat facility. The company has successfully increased its annual production capacity from 7 billion to 12 billion packs, marking a substantial 71% growth in its aseptic packaging solutions output.

Capacity Expansion Details

According to a disclosure filed by UFLEX under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company completed the capacity enhancement on October 3, 2025. The expansion was achieved through debottlenecking of the existing facility, allowing for a more efficient production process.

Strategic Implications

This expansion represents a significant boost in UFLEX's production capabilities for aseptic packaging solutions. Aseptic packaging is crucial in the food and beverage industry, as it allows products to be stored for extended periods without refrigeration while maintaining product safety and quality.

Market Position

The increased capacity is likely to strengthen UFLEX's position in the competitive packaging industry. With the ability to produce an additional 5 billion packs annually, the company is well-positioned to meet growing market demands and potentially capture a larger market share in the aseptic packaging segment.

Future Outlook

While the company has not provided specific details on the market impact or financial implications of this expansion, the significant increase in production capacity suggests UFLEX's confidence in the growing demand for aseptic packaging solutions. This move aligns with global trends towards convenient, long-shelf-life packaging options in the food and beverage sector.

As the market reacts to this development, stakeholders will be keen to observe how UFLEX leverages this expanded capacity to drive growth and enhance its market presence in the coming quarters.

Historical Stock Returns for UFLEX

1 Day5 Days1 Month6 Months1 Year5 Years
+0.46%-1.22%-3.61%-2.61%-4.53%+70.73%

UFLEX Achieves Record Revenue of INR 14,800 Crores in FY23, Navigating Forex Challenges

2 min read     Updated on 05 Sept 2025, 07:02 PM
scanx
Reviewed by
Riya DeyScanX News Team
Overview

UFLEX Limited achieved its highest-ever revenue of INR 14,800.00 crores in FY23, marking an 11% growth. The packaging business grew by 33%, with aseptic packaging showing 116% volume growth. Indian operations posted record turnover, volumes, and profitability. However, EBITDA declined by 9% to INR 2,070.00 crores due to forex losses of INR 340.00 crores. The company is making strategic investments, including a $70 million PET chips plant in Egypt. UFLEX anticipates market recovery in European and US markets by Q3 and Q4 of FY24.

18624733

*this image is generated using AI for illustrative purposes only.

UFLEX Limited, a leading player in the packaging industry, has reported its highest-ever revenue of INR 14,800.00 crores for the fiscal year 2023, marking a robust growth of over 11% compared to the previous year. The company's performance highlights its resilience in the face of global economic challenges and currency fluctuations.

Record-Breaking Performance in Packaging Business

The company's packaging business emerged as a standout performer, achieving its highest-ever sales with a remarkable 33% growth. This growth encompasses both the aseptic and flexible packaging segments, underscoring UFLEX's strong position in the market.

Aseptic Packaging Success

UFLEX's aseptic packaging business demonstrated exceptional performance, operating at near-full capacity with 93-94% utilization. The segment recorded an impressive 116% volume growth, contributing significantly to the company's overall revenue increase.

Indian Operations Excel

The company's Indian operations achieved a trifecta of success, posting record turnover, volumes, and profitability. This strong domestic performance helped offset challenges in other markets.

Navigating Global Challenges

Despite the record revenue, UFLEX faced headwinds that impacted its profitability. The company's EBITDA declined by 9% to INR 2,070.00 crores from INR 2,278.00 crores in the previous year. A major factor in this decline was significant foreign exchange losses totaling INR 340.00 crores.

Foreign Exchange Impacts

The forex losses were primarily attributed to two factors:

  1. Egyptian currency devaluations, resulting in a loss of INR 150.00 crores
  2. Strengthening of the US dollar against other currencies, leading to a loss of INR 190.00 crores

Packaging Films Business Challenges

UFLEX's packaging films business encountered difficulties due to overcapacity and reduced demand in European and US markets. These challenges were largely driven by higher energy costs and increased interest rates in these regions.

Strategic Investments for Future Growth

To strengthen its market position and reduce raw material dependence, UFLEX is making strategic investments:

  1. A $70 million investment in a PET chips plant in Egypt with a 200,000 tons capacity
  2. Commissioning of a 63,000 tons facility in Dharwad, India
  3. Launch of an 18,000 tons CPP plant in Dubai

Outlook

UFLEX management anticipates a gradual recovery in European and US markets by the third and fourth quarters of FY24. This optimistic outlook, coupled with the company's strategic investments and strong performance in key segments, positions UFLEX to potentially capitalize on improving market conditions.

Financial Highlights FY23 YoY Change
Revenue 14,800.00 +11%
EBITDA 2,070.00 -9%
Forex Losses 340.00 N/A
Packaging Business Growth N/A +33%
Aseptic Packaging Volume Growth N/A +116%

UFLEX's performance in FY23 demonstrates its ability to achieve significant revenue growth despite challenging global economic conditions. The company's focus on strategic investments and its strong performance in key segments, particularly in packaging and Indian operations, provide a solid foundation for future growth as it navigates through current market challenges.

Historical Stock Returns for UFLEX

1 Day5 Days1 Month6 Months1 Year5 Years
+0.46%-1.22%-3.61%-2.61%-4.53%+70.73%
More News on UFLEX
Explore Other Articles
542.65
+2.50
(+0.46%)